Biomarkers of cadmium and arsenic interactions

Toxicology and Applied Pharmacology

Volumn 206, Issue 2, 2005, Pages 191-197

  Nordberg, G F ^a   Jin, T ^a,b   Hong, F ^c   Zhang, A ^c   Buchet, J P ^d   Bernard, A ^d  

^a UMEÅ UNIVERSITY   (Sweden)

^b FUDAN UNIVERSITY   (China)

^c GUIZHOU MEDICAL UNIVERSITY   (China)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Arsenic; Cadmium; Human health effects; Renal dysfunction; Toxicity; Urinary proteins

Indexed keywords

ALBUMIN; ARSENIC; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CADMIUM; N ACETYL BETA GLUCOSAMINIDASE; RETINOL BINDING PROTEIN;

ATOMIC ABSORPTION SPECTROMETRY; CHEMICAL INTERACTION; CONFERENCE PAPER; CONTAMINATION; DOSE RESPONSE; EXPOSURE; GEOMETRY; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; MEASUREMENT; METHYLATION; NEPHROTOXICITY; NONHUMAN; PROTEIN BINDING; PROTEOMICS;

ACETYLGLUCOSAMINIDASE; ALBUMINURIA; ARSENIC; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CADMIUM; FEMALE; HUMANS; KIDNEY; MALE;

ANIMALIA; URIA;

EID: 20444494268     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.11.028     Document Type: Conference Paper

References (25)

1. ATSDR Toxicological Profile for Arsenic 2000 Agency for Toxic Substances and Disease Registry Atlanta, GA (www.atsdr.cdc.gov)
2. ATSDR 2001 CERCLA Priority List of Hazardous Substance 2001 U.S. Department of Health and Human Services (www.atsdr.cdc.gov)
3. A. Bernard Renal dysfunction induced by cadmium: biomarkers of critical effects BioMetals 17 2004 519 523
4. A. Bernard, H. Roels, and N. Thielemans Assessment of the causality of the cadmium-protein relationships in the urine of the general population with reference to the Cadmibel study G.F. Nordberg R.F.M. Herber L. Alessio Cadmium in the Human Environment: Toxicity and Carcinogenicity vol. 118 1992 IARC Lyon France 341 346
5. A. Bernard, N. Thielemans, and R. Lauwerys Urinary protein 1 or Clara cell protein: a new sensitive marker of proximal tubular dysfunction Kidney Int. 46 1994 S34 S37
6. J.P. Buchet, J.F. Heillier, A. Bernard, D. Lison, T. Jin, X. Wu, Q. Kong, and G. Nordberg Urinary protein excretion in humans exposed to arsenic and cadmium Int. Arch. Occup. Environ. Health 76 2003 111 120
7. E.N. David, V.M. Garry, J.E. Steven, and P.M. Thomas Total arsenic in urine: palladium-persulfate vs. nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry Clin. Chem. 37 9 1991 1575 1579
8. R. Diaz-Barriga, M.A. Santos, J.J. Mejia, L. Batres, L. Yanez, L. Carrizales, E. Vera, L.M. del Razo, and M.E. Cebrian Arsenic and cadmium exposure in children living near a smelter complex in San Luis Potosi, Mexico Environ. Res. 62 1993 242 250
9. M. Fay, and M.M. Mumtaz Development of a priority list of chemical mixtures occurring at 1188 hazardous waste sites using the HazDat database Food Chem. Toxicol. 34 1996 1163 1165
10. R.S. Hare Endogenous creatinine in serum and urine Proc. Exp. Biol. 74 1950 148 151
11. J.F. Hochadel, and M.P. Waalkes Sequence of exposure to cadmium and arsenic determines the extent of toxic effects in male Fisher rats Toxicology 116 1997 89 98
12. F. Hong, T. Jin, and A. Zhang Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population BioMetals 17 2004 573 580
13. IARC Beryllium, cadmium, mercury and lead exposures in the glass manufacturing industry Monographs on the Evaluation of the Carcinogenic Risks to Humans vol. 58 1993 Lyon France 119 237
14. L. Jarup, M. Berglund, C.G. Elinder, G. Nordberg, and M. Vahter Health effects of cadmium exposure-A review of the literature and a risk estimate Scand. J. Work, Environ. Health 24 Suppl. 1 1998 1 50
15. T. Jin, G.F. Nordberg, X. Wu, T. Ye, Q. Kong, Z. Wang, F. Zhuang, and S. Cai Urinary N-acetyl-β-d-glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population Environ. Res., Section A 81 1999 167 173
16. T. Jin, M. Nordberg, W. Frech, X. Dumont, A. Bernard, T. Ye, Q. Kong, Z. Wang, P. Li, N.G. Lundstrom, Y. Li, and G. Nordberg Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China BioMetals 15 2002 397 410
17. T. Jin, X. Wu, Y. Tang, M. Nordberg, A. Bernard, T. Ye, Q. Kong, N.G. Lundstrom, and G.F. Nordberg Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China BioMetals 17 2004 525 530
18. J. Liu, Y. Liu, S.M. Habebu, M.P. Waalkes, and C.D. Klaassen Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice Toxicology 147 2000 157 166
19. R.G. Neuman, and M.P. Cohen Improved competitive enzyme-linked immunoassay (ELISA) for albuminuria Clin. Chim. Acta 179 3 1989 229 237
20. G.F. Nordberg Cadmium and health in the 21st century-historical remarks and trends for the future BioMetals 17 2004 485 489
21. G. Nordberg, T. Jin, A. Bernard, S. Fierens, J.P. Buchet, T. Ye, Q. Kong, and H. Wang Low bone density and renal dysfunction following environmental cadmium exposure in China Ambio 31 2002 478 481
22. R.G. Price Measurement of N-acetyl-β-d-glucosaminidase and it isoenzyme in urine: Methods and clinical applications Eur. J. Clin. Chem. Clin. Biochem. 30 1992 693 705
23. E.T. Snow Metal carcinogenesis: mechanistic implications Phamacol. Ther. 53 1992 31 65
24. WHO, 2002. Principles and methods for the assessment of risk from essential trace elements IPCS No. 228.
25. A.H. Zhang, X.X. Huang, X.Y. Jiang, Y.C. Guo, P. Luo, and S.Z. Xue The progress of endemic arsenism due to burning coal contain arsenic Met. Ions Biol. Med. 6 2000 53 55